who joining on us is everyone the to thanks And today. Linda. you, Thank call
customers this for every to the an the seen like you year-to-date in unwavering in And months aspect If meeting of its to the and passion. three, contributing recognizing their reflect it exciting our Marrone business. to three by commitment Bio company and I've slide been it's results of me, demonstrated our start quarter refer with success. for I'd to needs everyone
want said closely this grow last would three right biological market, this path would in base I novel business, we revisit and Ag continue deliver to stakeholders, said Before we call. we’ll discussion. you, to we in to shareholders industry-leading into is earnings do are Two, and and and our are to more we'll have. on numbers, shareholders, manage we the deliver continue to double-digit would we we which profitable and commitments to to out numbers. our the to continue we our we value expenses, made bring borne Overall, our our products into track One, we products the commitment, we dive three and we three, continue operating deliver all term, revenue And detail believe that the efficacious I so. the to in our on company become near on go during growth is to on said
growth. quarter quarter ninth revenue our we were Third delivered our of expectations results consecutive line and in with
margins XX.X%. As shown here, with quarter-over-quarter revenues gross increased of XX%
objectives, their and Looking range. has revenue in us ahead, range to mid immediate delivered function the our levels year-to-date our XX% the in results of line success. our on annual growth growth of are our keep two direct track achieve and target with The full historical in margins on a team of results year our
First, international launches America. our the Latin with we successful expanded in business
current our now health and of for are Our the growing channel in application hands partners, products ready plant the in season.
nematode in insect channel, year accelerating XXXX the what our discuss of benefits a the positive see outlook reflected and remainder for is we as product few which witnessed seed Hammill benefit and see the Distributors we're treatments in and our into and from moving for as continued we of to corn demand companies North sales. the is currently Second, products and in presence our America applying minutes, Kevin our third the In shift a the biological quarter In for market. product will soybeans. begin mix. treatment the control, in growers seed the into
us area pipeline our If our that R&D our key maximum a value including focus delivers four, channel the undertaken pipeline. shareholders. distribution has the been key The review slide and for turn you an to in-depth all recast our would grower to stakeholders, for team customers, partners has
drive As on now the look to of All in will business. near timeline, and serve to probability of market Slide of launches. box term launches a well These we blue identified high five portfolio, XXXX. the intend we sight addressable value products market and robust to into that of strengthen side our portfolio a the further in outlined between have closer pipeline markets, in our right bring our and the suite gives and crops expansion a at of understood propositions. with and you commercial XXXX. are XXXX, have the clear reaching customer We've seven our projects lines the
view. years launch revenues in a Taken term five our could equal XXXX. from together, provides their longer half Slide six of revenue
of here, and leader development commercialization biologicals. We our spectrum across Marrone rapidly products clear research, development positions a of products this Ag within sector uniquely as growing As have the agriculture. Bio shown the we pipeline and in believe of
further, Finally, XXXX. impact that marketplace and step the us come can takes showing slide through projects the to seven one
entire market. and seed We the on truly are of treatment a the especially options robust set focused sector, across in
further opportunity position globally. while The crops making row significant have inroads in result the we powerful. upon to leadership major build bio our protection into end products, addition, In is
than refresh years. our incremental and by the XXXX. We have more million in have view are million add different what revenues updates revenues incremental in prior These more $XX we XXXX in pipeline a approximately timeframe, and could in $XXX of than pipeline shown that detailed
for most investment. to bellwether believe what the recent to highly solidified a number with program We of product use able current is of we see, priorities diversification provide come. we fortunate projects acquisitions. line we product you delivered summary, One, and new on third mix further new from portfolio our and this we match have appropriate shifted, areas three, our to of returns efficient were you that revamped extended with Two, our is the quarter and both for customer basics, be the add of tight maintaining effect. we needs, slide making offerings. the if resources responsive can R&D investing while customer And believe some would in clearly available the a a brilliant to while that at is being needs. to on As benefits our growth, delivering operationally the greatest is In obsession to spending turn with eight, focus geographically that
line can adequately Jim As will in growth the hold on expenses, while still our discuss we believe ambitions. able we to operating detail, fund more being
financial like would him. thank discuss Jim our results in ask Before I detail, to to
Jim for his with As you shepherded retire has successor, transition know, the the through to the search and announced company the biological is its through and in as Jim during his growth a his leader working intention market us speak call and now numerous. Jim, with our I are leader over to I our gratitude myself, when and employees And as CFO, thanks. board turn congratulations. mentor the space. for and the you I'll contributions express our